| Oak Knoll Healthcare Center | |
| 9 Arbetter Drive, Framingham, Massachusetts 01701 | |
| (508) 877-3300 | |
| Name | Oak Knoll Healthcare Center |
|---|---|
| Location | 9 Arbetter Drive, Framingham, Massachusetts |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 123 |
| Occupancy Rate | 67.72% |
| Medicare ID (CCN) | 225682 |
| Legal Business Name | Arbetter Corporation |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1770516346 |
| Organization Name | ARBETTER CORPORATION |
| Doing Business As | OAK KNOLL HEALTHCARE CENTER |
| Address | 9 Arbetter Dr, Framingham, MA 01701 |
| Phone Number | 508-877-3300 |
News Archive
Four of the nation's leading public health officials laid out opportunities and challenges in the diverse area of patient care in the 21st century at the recently concluded U.S. Pharmacopeial Convention's 2010 Membership Meeting in Washington, D.C., emphasizing the critical nature of partnerships and the evolving role of quality standards to meet modern threats.
Early structural changes in the back of the eye — now visible with a newly developed eye scan — may indicate the onset of Alzheimer's disease. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology this week in Seattle, Wash.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the debut of its new LED Fiber Optic Illuminator Module. The new LED Module is designed for ease of integration by medical OEMs in endoscopy, surgical microscopy and headlamp applications.
Featured in the October edition of the Journal of Thoracic Oncology (JTO), data from The Tarceva Lung Cancer Survival Treatment (TRUST) confirms the safety and efficacy profile of erlotinib, a highly potent oral active, reversible inhibitor of epidermal growth factor receptor (EGFR) tyrosine-kinase (TK) activity in a large heterogeneous non-small cell lung cancer (NSCLC) population.
Patients with basilar artery occlusion should undergo recanalization therapy as soon as possible, show data from BASICS.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Four of the nation's leading public health officials laid out opportunities and challenges in the diverse area of patient care in the 21st century at the recently concluded U.S. Pharmacopeial Convention's 2010 Membership Meeting in Washington, D.C., emphasizing the critical nature of partnerships and the evolving role of quality standards to meet modern threats.
Early structural changes in the back of the eye — now visible with a newly developed eye scan — may indicate the onset of Alzheimer's disease. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology this week in Seattle, Wash.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the debut of its new LED Fiber Optic Illuminator Module. The new LED Module is designed for ease of integration by medical OEMs in endoscopy, surgical microscopy and headlamp applications.
Featured in the October edition of the Journal of Thoracic Oncology (JTO), data from The Tarceva Lung Cancer Survival Treatment (TRUST) confirms the safety and efficacy profile of erlotinib, a highly potent oral active, reversible inhibitor of epidermal growth factor receptor (EGFR) tyrosine-kinase (TK) activity in a large heterogeneous non-small cell lung cancer (NSCLC) population.
Patients with basilar artery occlusion should undergo recanalization therapy as soon as possible, show data from BASICS.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $39000 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 14.44 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 14.77 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 83.62 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.97 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 8.42 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.44 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.71 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 90.57 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 15.69 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 83.37 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 3.2 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 28.55 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 15.44 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 8.4 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 84.62 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 78.85 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 91.04 | 82.93 |
News Archive
Four of the nation's leading public health officials laid out opportunities and challenges in the diverse area of patient care in the 21st century at the recently concluded U.S. Pharmacopeial Convention's 2010 Membership Meeting in Washington, D.C., emphasizing the critical nature of partnerships and the evolving role of quality standards to meet modern threats.
Early structural changes in the back of the eye — now visible with a newly developed eye scan — may indicate the onset of Alzheimer's disease. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology this week in Seattle, Wash.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the debut of its new LED Fiber Optic Illuminator Module. The new LED Module is designed for ease of integration by medical OEMs in endoscopy, surgical microscopy and headlamp applications.
Featured in the October edition of the Journal of Thoracic Oncology (JTO), data from The Tarceva Lung Cancer Survival Treatment (TRUST) confirms the safety and efficacy profile of erlotinib, a highly potent oral active, reversible inhibitor of epidermal growth factor receptor (EGFR) tyrosine-kinase (TK) activity in a large heterogeneous non-small cell lung cancer (NSCLC) population.
Patients with basilar artery occlusion should undergo recanalization therapy as soon as possible, show data from BASICS.
› Verified 8 days ago
Casa De Ramana Rehabilitation Center Location: 485 Franklin Street, Framingham, Massachusetts 01702 Phone: (508) 872-8801 | |
St Patrick's Manor Location: 863 Central Street, Framingham, Massachusetts 01701 Phone: (508) 879-8000 | |
Bethany Skilled Nursing Facility Location: 97 Bethany Road, Framingham, Massachusetts 01701 Phone: (508) 872-6750 | |
Oak Knoll Healthcare Center Location: 9 Arbetter Drive, Framingham, Massachusetts 01701 Phone: (508) 877-3300 |